Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The method increases stem-like cells for better skin regeneration.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Blocking SEPT4 might help heal wounds and regrow hair faster.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Nilotinib can cause skin issues like red bumps and hair loss.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

DA-9401 helps protect rat testis from finasteride damage.